Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
iBio, Inc. shareholders approved Advisory vote on executive compensation at the 2022-12-08 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
Proposal 3 The stockholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers ("say-on-pay"), as disclosed in the Definitive Proxy Statement. The results of the voting for this approved proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 780,830 537,904 28,727 2,552,791
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
iBio, Inc. shareholders approved Election of Class II directors at the 2022-12-08 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
Proposal 1 The following two (2) nominees named as Class II directors of the Company’s Board of Directors, each to serve a three-year term expiring at the 2025 Annual Meeting of Stockholders and until such director’s successor is duly elected and qualified, were elected with the following votes: Name of Director Votes For Withheld Broker Non-Votes 1. Dr. Linda W. Armstrong 1,051,212 296,249 0 2. Dr. Alexandra Kropotova 1,027,547 319,914 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
iBio, Inc. shareholders approved Ratification of CohnReznick LLP as independent registered public accounting firm for the year ending June 30, 2022 at the 2022-12-08 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
Proposal 2 The stockholders ratified the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the year ending June 30, 2022 based on the votes set forth below: Votes For Votes Against Abstentions Broker Non-Votes 3,226,366 607,132 66,754 0
View on SEC.gov